Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11029342 | European Journal of Cancer | 2018 | 10 Pages |
Abstract
The epidemiologic landscape of HPV-positive OPSCC is evolving, with a dramatic increase in the proportion of HPV-associated OPSCC among patients 70 years or older. HPV remains a powerful predictor of improved survival in elderly patients, but with less pronounced effect on older adults undergoing definitive RT.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Diana J. Lu, Michael Luu, Alain Mita, Kevin Scher, Stephen L. Shiao, Emi P. Yoshida, Mark P. Sittig, Jon Mallen-St Clair, Allen S. Ho, Zachary S. Zumsteg,